NCI Funding Trends
Funding amounts and percentages reflect actual obligations for each fiscal year.
NCI Funding
| Mechanism | 2018** | 2019** | 2020** | 2021** | 2022** | 2023** |
|---|---|---|---|---|---|---|
| Total NCI | $5,927.6 | $5,992.3 | $6,383.3 | $6,442.7 | $6,833.7 | $7,186.8 |
| Research Project Grants | 2,450.6 | 2,541.7 | 2,749.4 | 2,822.4 | 2,966.5 | 3,145.2 |
| Cancer Centers | 331.4 | 337.1 | 382.0 | 344.7 |
339.7 |
353.5 |
| SPOREs | 115.8 | 110.7 | 113.2 | 119.6 |
128.2 |
124.1 |
| Other P50s/P20s | 0.0 | 7.4 | 7.9 | 3.3 |
13.2 |
5.3 |
| Specialized Centers | 178.3 | 200.8 | 110.7 | 95.9 |
105.9 |
141.5 |
| Clinical Cooperative Groups | 255.3 | 290.1 | 295.6 | 300.0 |
307.9 |
303.6 |
| R&D Contracts | 825.4 | 768.1 | 823.0 | 812.2 |
835.8 |
899.1 |
| Intramural Research | 945.5 | 964.9 | 1,072.6 | 1,102.5 |
1,230.4 |
1,278.5 |
| Other Mechanisms* | 825.3 | 771.5 | 829.0 | 842.0 |
906.1 |
936.0 |
|
*Other mechanisms includes the Career Program, Cancer Education, Minority Biomedical Research Support, Other Research Grants, National Research Service Awards (NRSA), Research Management & Support, and Buildings & Facilities. |
||||||
|
**Fiscal years 2023 through 2017 includes Cancer Moonshot funding appropriated that fiscal year and excludes all carryover obligations for fiscal years 2023 through 2018. |
||||||
Percent Change by Mechanism
| Mechanism | 2017 to 2018** | 2018 to 2019** | 2019 to 2020** | 2020 to 2021** | 2021 to 2022** | 2022 to 2023** |
|---|---|---|---|---|---|---|
| Total NCI | 5.2% | 1.1% | 6.5% | 0.9% | 6.1% | 5.2% |
| Research Project Grants | 7.6% | 3.7% | 8.2% | 2.7% | 5.1% | 6.0% |
| Cancer Centers | 5.9% | 1.7% | 13.3% | -9.8% |
-1.5% |
4.1% |
| SPOREs | 3.9% | -4.4% | 2.3% | 5.6% |
7.2% |
-3.2% |
| Other P50s/P20s | -100.0% | 0.0% | 6.5% | -58.4% |
299.4% |
-59.9% |
| Specialized Centers | 31.5% | 12.6% | -44.9% | -13.3% |
10.4% |
33.6% |
| Clinical Cooperative Groups | 4.1% | 13.6% | 1.9% | 1.5% |
2.6% |
-1.4% |
| R&D Contracts | -6.2% | -6.9% | 7.1% | -1.3% |
2.9% |
7.6 |
| Intramural Research | 5.1% | 2.1% | 11.2% | 2.8% |
11.6% |
3.9 |
| Other Mechanisms* | 7.0% | -6.5% | 7.5% | 1.6% |
7.6% |
3.3% |
| *Other mechanisms includes the Career Program, Cancer Education, Minority Biomedical Research Support, Other Research Grants, National Research Service Awards (NRSA), Research Management & Support, and Buildings & Facilities. | ||||||
| **Fiscal years 2023 through 2017 includes Cancer Moonshot funding appropriated that fiscal year and excludes all carryover obligations for fiscal years 2023 through 2018. | ||||||
Percent Share of Total NCI Dollars
| Mechanism | 2018** | 2019** | 2020** | 2021** | 2022** | 2023** |
|---|---|---|---|---|---|---|
| Research Project Grants | 41.3% | 42.4% | 43.1% | 43.8% |
43.4% |
43.8% |
| Cancer Centers | 5.6% | 5.6% | 6.0% | 5.4% |
5.0% |
4.9% |
| SPOREs | 2.0% | 1.8% | 1.8% | 1.9% |
1.9% |
1.7% |
| Other P50s/P20s | 0.0% | 0.1% | 0.1% | 0.1% |
0.2% |
0.1% |
| Specialized Centers | 3.0% | 3.4% | 1.7% | 1.5% |
1.6% |
2.0% |
| Clinical Cooperative Groups | 4.3% | 4.8% | 4.6% | 4.7% |
4.5% |
4.2% |
| R&D Contracts | 13.9% | 12.8% | 12.9% | 12.6% |
12.2% |
12.5% |
| Intramural Research | 16.0% | 16.1% | 16.8% | 17.1% |
18.0% |
17.8% |
| Other Mechanisms* | 13.9% | 12.9% | 13.0% | 13.1% |
13.3% |
13.0% |
| *Other mechanisms includes the Career Program, Cancer Education, Minority Biomedical Research Support, Other Research Grants, National Research Service Awards (NRSA), Research Management & Support, and Buildings & Facilities. | ||||||
| **Fiscal years 2023 through 2017 includes Cancer Moonshot funding appropriated that fiscal year and excludes all carryover obligations for fiscal years 2023 through 2018. | ||||||